A citation-based method for searching scientific literature

D Reisman, S Glaros, E A Thompson. Oncogene 2009
Times Cited: 420







List of co-cited articles
641 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


SWI/SNF nucleosome remodellers and cancer.
Boris G Wilson, Charles W M Roberts. Nat Rev Cancer 2011
805
20

Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy.
Cigall Kadoch, Diana C Hargreaves, Courtney Hodges, Laura Elias, Lena Ho, Jeff Ranish, Gerald R Crabtree. Nat Genet 2013
733
16

Reconstitution of a core chromatin remodeling complex from SWI/SNF subunits.
M L Phelan, S Sif, G J Narlikar, R E Kingston. Mol Cell 1999
479
14

Frequent BRG1/SMARCA4-inactivating mutations in human lung cancer cell lines.
Pedro P Medina, Octavio A Romero, Takashi Kohno, Luis M Montuenga, Ruben Pio, Jun Yokota, Montse Sanchez-Cespedes. Hum Mutat 2008
182
14

ARID1A deficiency promotes mutability and potentiates therapeutic antitumor immunity unleashed by immune checkpoint blockade.
Jianfeng Shen, Zhenlin Ju, Wei Zhao, Lulu Wang, Yang Peng, Zhongqi Ge, Zachary D Nagel, Jun Zou, Chen Wang, Prabodh Kapoor,[...]. Nat Med 2018
213
12

ARID1A mutations in endometriosis-associated ovarian carcinomas.
Kimberly C Wiegand, Sohrab P Shah, Osama M Al-Agha, Yongjun Zhao, Kane Tse, Thomas Zeng, Janine Senz, Melissa K McConechy, Michael S Anglesio, Steve E Kalloger,[...]. N Engl J Med 2010
11

The spectrum of SWI/SNF mutations, ubiquitous in human cancers.
A Hunter Shain, Jonathan R Pollack. PLoS One 2013
332
11


Loss of BRG1/BRM in human lung cancer cell lines and primary lung cancers: correlation with poor prognosis.
David N Reisman, Janiece Sciarrotta, Weidong Wang, William K Funkhouser, Bernard E Weissman. Cancer Res 2003
277
10

SWI/SNF chromatin remodeling and human malignancies.
Julien Masliah-Planchon, Ivan Bièche, Jean-Marc Guinebretière, Franck Bourdeaut, Olivier Delattre. Annu Rev Pathol 2015
182
10

Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma.
Diana Miao, Claire A Margolis, Wenhua Gao, Martin H Voss, Wei Li, Dylan J Martini, Craig Norton, Dominick Bossé, Stephanie M Wankowicz, Dana Cullen,[...]. Science 2018
531
10


The SWI/SNF complex--chromatin and cancer.
Charles W M Roberts, Stuart H Orkin. Nat Rev Cancer 2004
440
9

Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer.
Kai Wang, Junsuo Kan, Siu Tsan Yuen, Stephanie T Shi, Kent Man Chu, Simon Law, Tsun Leung Chan, Zhengyan Kan, Annie S Y Chan, Wai Yin Tsui,[...]. Nat Genet 2011
539
9

Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma.
Ignacio Varela, Patrick Tarpey, Keiran Raine, Dachuan Huang, Choon Kiat Ong, Philip Stephens, Helen Davies, David Jones, Meng-Lay Lin, Jon Teague,[...]. Nature 2011
862
9

Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer.
I Versteege, N Sévenet, J Lange, M F Rousseau-Merck, P Ambros, R Handgretinger, A Aurias, O Delattre. Nature 1998
9

Germline and somatic SMARCA4 mutations characterize small cell carcinoma of the ovary, hypercalcemic type.
Leora Witkowski, Jian Carrot-Zhang, Steffen Albrecht, Somayyeh Fahiminiya, Nancy Hamel, Eva Tomiak, David Grynspan, Emmanouil Saloustros, Javad Nadaf, Barbara Rivera,[...]. Nat Genet 2014
272
9

Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma.
Siân Jones, Tian-Li Wang, Ie-Ming Shih, Tsui-Lien Mao, Kentaro Nakayama, Richard Roden, Ruth Glas, Dennis Slamon, Luis A Diaz, Bert Vogelstein,[...]. Science 2010
844
9

ARID1A mutations in cancer: another epigenetic tumor suppressor?
Jennifer N Wu, Charles W M Roberts. Cancer Discov 2013
260
9

Functional epigenetics approach identifies BRM/SMARCA2 as a critical synthetic lethal target in BRG1-deficient cancers.
Gregory R Hoffman, Rami Rahal, Frank Buxton, Kay Xiang, Gregory McAllister, Elizabeth Frias, Linda Bagdasarian, Janina Huber, Alicia Lindeman, Dongshu Chen,[...]. Proc Natl Acad Sci U S A 2014
216
8

Dual loss of the SWI/SNF complex ATPases SMARCA4/BRG1 and SMARCA2/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcaemic type.
Anthony N Karnezis, Yemin Wang, Pilar Ramos, William Pd Hendricks, Esther Oliva, Emanuela D'Angelo, Jaime Prat, Marisa R Nucci, Torsten O Nielsen, Christine Chow,[...]. J Pathol 2016
123
8

Vulnerabilities of mutant SWI/SNF complexes in cancer.
Katherine C Helming, Xiaofeng Wang, Charles W M Roberts. Cancer Cell 2014
160
8

BAP1 loss defines a new class of renal cell carcinoma.
Samuel Peña-Llopis, Silvia Vega-Rubín-de-Celis, Arnold Liao, Nan Leng, Andrea Pavía-Jiménez, Shanshan Wang, Toshinari Yamasaki, Leah Zhrebker, Sharanya Sivanand, Patrick Spence,[...]. Nat Genet 2012
598
8

Loss of ARID1A expression and its relationship with PI3K-Akt pathway alterations, TP53 and microsatellite instability in endometrial cancer.
Tjalling Bosse, Natalja T ter Haar, Laura M Seeber, Paul J v Diest, Frederik J Hes, Hans F A Vasen, Remi A Nout, Carien L Creutzberg, Hans Morreau, Vincent T H B M Smit. Mod Pathol 2013
125
8

Modular Organization and Assembly of SWI/SNF Family Chromatin Remodeling Complexes.
Nazar Mashtalir, Andrew R D'Avino, Brittany C Michel, Jie Luo, Joshua Pan, Jordan E Otto, Hayley J Zullow, Zachary M McKenzie, Rachel L Kubiak, Roodolph St Pierre,[...]. Cell 2018
226
8

The reversible epigenetic silencing of BRM: implications for clinical targeted therapy.
S Glaros, G M Cirrincione, C Muchardt, C G Kleer, C W Michael, D Reisman. Oncogene 2007
109
7

Epigenetic antagonism between polycomb and SWI/SNF complexes during oncogenic transformation.
Boris G Wilson, Xi Wang, Xiaohua Shen, Elizabeth S McKenna, Madeleine E Lemieux, Yoon-Jae Cho, Edward C Koellhoffer, Scott L Pomeroy, Stuart H Orkin, Charles W M Roberts. Cancer Cell 2010
393
7

A Brg1 null mutation in the mouse reveals functional differences among mammalian SWI/SNF complexes.
S Bultman, T Gebuhr, D Yee, C La Mantia, J Nicholson, A Gilliam, F Randazzo, D Metzger, P Chambon, G Crabtree,[...]. Mol Cell 2000
625
7

Somatic mutations in the chromatin remodeling gene ARID1A occur in several tumor types.
Siân Jones, Meng Li, D Williams Parsons, Xiaosong Zhang, Jelle Wesseling, Petra Kristel, Marjanka K Schmidt, Sanford Markowitz, Hai Yan, Darell Bigner,[...]. Hum Mutat 2012
208
7

Residual complexes containing SMARCA2 (BRM) underlie the oncogenic drive of SMARCA4 (BRG1) mutation.
Boris G Wilson, Katherine C Helming, Xiaofeng Wang, Youngha Kim, Francisca Vazquez, Zainab Jagani, William C Hahn, Charles W M Roberts. Mol Cell Biol 2014
126
7

Understanding the words of chromatin regulation.
Jiang I Wu, Julie Lessard, Gerald R Crabtree. Cell 2009
258
7

ARID1A gene mutation in ovarian and endometrial cancers (Review).
Takashi Takeda, Kouji Banno, Ryuichiro Okawa, Megumi Yanokura, Moito Iijima, Haruko Irie-Kunitomi, Kanako Nakamura, Miho Iida, Masataka Adachi, Kiyoko Umene,[...]. Oncol Rep 2016
90
7

The Many Roles of BAF (mSWI/SNF) and PBAF Complexes in Cancer.
Courtney Hodges, Jacob G Kirkland, Gerald R Crabtree. Cold Spring Harb Perspect Med 2016
190
7

A non-canonical SWI/SNF complex is a synthetic lethal target in cancers driven by BAF complex perturbation.
Brittany C Michel, Andrew R D'Avino, Seth H Cassel, Nazar Mashtalir, Zachary M McKenzie, Matthew J McBride, Alfredo M Valencia, Qianhe Zhou, Michael Bocker, Luis M M Soares,[...]. Nat Cell Biol 2018
132
7

Chromatin remodeling factors and BRM/BRG1 expression as prognostic indicators in non-small cell lung cancer.
Junya Fukuoka, Takeshi Fujii, Joanna H Shih, Tatiana Dracheva, Daoud Meerzaman, Audrey Player, Kyeong Hong, Sharon Settnek, Ajay Gupta, Kenneth Buetow,[...]. Clin Cancer Res 2004
167
6

Purification and biochemical heterogeneity of the mammalian SWI-SNF complex.
W Wang, J Côté, Y Xue, S Zhou, P A Khavari, S R Biggar, C Muchardt, G V Kalpana, S P Goff, M Yaniv,[...]. EMBO J 1996
615
6

Highly penetrant, rapid tumorigenesis through conditional inversion of the tumor suppressor gene Snf5.
Charles W M Roberts, Monique M Leroux, Mark D Fleming, Stuart H Orkin. Cancer Cell 2002
221
6


Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genes.
Zhi Jiang Zang, Ioana Cutcutache, Song Ling Poon, Shen Li Zhang, John R McPherson, Jiong Tao, Vikneswari Rajasegaran, Hong Lee Heng, Niantao Deng, Anna Gan,[...]. Nat Genet 2012
459
6

The SWI/SNF chromatin remodelling complex is required for maintenance of lineage specific enhancers.
Burak H Alver, Kimberly H Kim, Ping Lu, Xiaofeng Wang, Haley E Manchester, Weishan Wang, Jeffrey R Haswell, Peter J Park, Charles W M Roberts. Nat Commun 2017
141
6

SMARCA4 and SMARCA2 deficiency in non-small cell lung cancer: immunohistochemical survey of 316 consecutive specimens.
Esther Herpel, Ralf J Rieker, Hendrik Dienemann, Thomas Muley, Michael Meister, Arndt Hartmann, Arne Warth, Abbas Agaimy. Ann Diagn Pathol 2017
72
8

Swi/Snf chromatin remodeling/tumor suppressor complex establishes nucleosome occupancy at target promoters.
Michael Y Tolstorukov, Courtney G Sansam, Ping Lu, Edward C Koellhoffer, Katherine C Helming, Burak H Alver, Erik J Tillman, Julia A Evans, Boris G Wilson, Peter J Park,[...]. Proc Natl Acad Sci U S A 2013
119
6

Hallmarks of cancer: the next generation.
Douglas Hanahan, Robert A Weinberg. Cell 2011
6

Loss of ARID1A expression is related to shorter progression-free survival and chemoresistance in ovarian clear cell carcinoma.
Atsuko Katagiri, Kentaro Nakayama, Mohammed Tanjimur Rahman, Munmun Rahman, Hiroshi Katagiri, Naomi Nakayama, Masako Ishikawa, Tomoka Ishibashi, Kouji Iida, Hiroshi Kobayashi,[...]. Mod Pathol 2012
134
6

BRG1 is a prognostic marker and potential therapeutic target in human breast cancer.
Jin Bai, Pengjin Mei, Cuipeng Zhang, Feifei Chen, Chen Li, Zhenqiang Pan, Hui Liu, Junnian Zheng. PLoS One 2013
64
9

The BRG1 ATPase of human SWI/SNF chromatin remodeling enzymes as a driver of cancer.
Qiong Wu, Jane B Lian, Janet L Stein, Gary S Stein, Jeffrey A Nickerson, Anthony N Imbalzano. Epigenomics 2017
64
9


ARID1A is downregulated in non-small cell lung cancer and regulates cell proliferation and apoptosis.
Yi Zhang, Xiaoman Xu, Meng Zhang, Xue Bai, Hui Li, Liang Kan, Huiyan Niu, Ping He. Tumour Biol 2014
31
19

Synthetic lethality by targeting EZH2 methyltransferase activity in ARID1A-mutated cancers.
Benjamin G Bitler, Katherine M Aird, Azat Garipov, Hua Li, Michael Amatangelo, Andrew V Kossenkov, David C Schultz, Qin Liu, Ie-Ming Shih, Jose R Conejo-Garcia,[...]. Nat Med 2015
385
6

The Brm gene suppressed at the post-transcriptional level in various human cell lines is inducible by transient HDAC inhibitor treatment, which exhibits antioncogenic potential.
Nobutake Yamamichi, Mitsue Yamamichi-Nishina, Taketoshi Mizutani, Hirotaka Watanabe, Shigeru Minoguchi, Nao Kobayashi, Satoko Kimura, Taiji Ito, Naohisa Yahagi, Masao Ichinose,[...]. Oncogene 2005
85
5


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.